Both in Biotechnology
Alpha Cognition vs Inhibikase Therapeutics
Over the past year ACOG returned +41.2% and IKT returned +5.4%; their daily moves had a correlation of 0.22.
ACOG +41.2% IKT +5.4%Growth of $1, one year, split-adjusted
| Metric | ACOG | IKT |
|---|---|---|
| Price | $8.74 | $1.55 |
| Market cap | $190.3M | $216.3M |
| Today | −4.90% | −7.19% |
| 1 month | +0.5% | −19.7% |
| 6 months | +46.9% | −18.8% |
| Year to date | +34.5% | −24.4% |
| 1 year | +33.0% | +8.4% |
| Revenue growth (YoY) | +267.6% | — |
| Gross margin | 93.6% | — |
| Net margin | −144.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 12.5× | — |
| Net cash | $41.4M | $159.0M |
| Dividend yield | — | — |
| Volatility (60d) | 44.9% | 50.9% |
| Short % of float | 1.8% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).